India Pharma Outlook Team | Monday, 17 November 2025
OMRON Healthcare Co., Ltd. has revealed further investment in the India-focused AI medtech startup TRICOG HEALTH INDIA PRIVATE LIMITED.
This marks OMRON Healthcare’s second investment round in Tricog, building on an initial investment made in March 2023, which enhances the partnership to boost business growth. WHO data indicates that cardiovascular and cerebrovascular diseases rank as the top two causes of death in India, and given the shifting lifestyles and a swiftly aging population, the number of affected patients is projected to keep rising.
Also Read: Sanofi's Teizeild Gains EU Backing for Type 1 Diabetes Breakthrough
At the same time, healthcare providers encounter several limitations: India has significantly fewer certified cardiologists per capita compared to Japan or the United States, resulting in a critical lack of specialists able to interpret ECG data.
Moreover, not every medical facility possesses the specialized equipment needed for advanced diagnostic procedures like ECG testing. To meet these demands and ensure prompt delivery of preventive care for individuals in need, Tricog Health combines advanced AI analytics developed from over ten years of ECG data with the expertise of more than 100 in-house clinical professionals.
Collectively, these advantages create the foundation for creating medical devices and services customized for frontline clinical procedures. Starting in 2023, OMRON Healthcare and Tricog Health have collaborated to develop and introduce KeeboHealth, a remote monitoring service for heart-failure patients that combines Tricog’s AI-driven ECG.